Clinical trials of AIDS vaccines in seronegative volunteers: vectors and combinations.
Graham
B S
BS
Vaccine Clinical Trials Network, Vanderbilt University School of Medicine, Nashville, TN 37232.
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000633:toxicity; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D015686:Gene Products, env / Q000008:administration & dosage / Q000276:immunology* / Q000633:toxicity; D015483:HIV Antibodies / Q000096:biosynthesis; D019302:HIV Envelope Protein gp160; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D011498:Protein Precursors / Q000008:administration & dosage / Q000276:immunology* / Q000633:toxicity; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology / Q000633:toxicity; D014611:Vaccination / Q000009:adverse effects; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology / Q000633:toxicity
D016915:AIDS Vaccines; D015686:Gene Products, env; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; C067702:HIVAC-1e; D011498:Protein Precursors; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; C053473:VaxSyn HIV-1 (gp160) vaccine